Scinai Immunotherapeutics annual current ratio
2017
2020
2021
2022
2023
2024
2025
Scinai Immunotherapeutics Current Ratio Growth & History (SCNI)
Scinai Immunotherapeutics's current ratio was 1.30 for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.30 | −0.03 | −2.12% |
| 2024 | 2024-12-31 | 1.32 | −1.74 | −56.74% |
| 2023 | 2023-12-31 | 3.06 | −3.09 | −50.21% |
| 2022 | 2022-12-31 | 6.15 | 3.69 | +150.26% |
| 2021 | 2021-12-31 | 2.46 | 2.29 | +1383.60% |
| 2020 | 2020-12-31 | 0.17 | — | — |
| 2017 | 2017-12-31 | 10.94 | — | — |
Scinai Immunotherapeutics quarterly current ratio
Q4.17
Q4.20
Q3.21
Q4.21
Q2.22
Q4.22
Q1.23
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.56 | 0.85 | +119.99% |
| Q1 2026 | 2026-03-31 | 1.35 | — | — |
| Q4 2025 | 2025-12-31 | 1.30 | −0.03 | −2.12% |
| Q2 2025 | 2025-06-30 | 0.71 | −1.48 | −67.52% |
| Q4 2024 | 2024-12-31 | 1.32 | −1.74 | −56.74% |
| Q2 2024 | 2024-06-30 | 2.19 | −1.93 | −46.85% |
| Q4 2023 | 2023-12-31 | 3.06 | −3.09 | −50.21% |
| Q2 2023 | 2023-06-30 | 4.12 | 2.41 | +141.24% |
| Q1 2023 | 2023-03-31 | 4.28 | — | — |
| Q4 2022 | 2022-12-31 | 6.15 | 3.69 | +150.26% |
| Q2 2022 | 2022-06-30 | 1.71 | — | — |
| Q4 2021 | 2021-12-31 | 2.46 | 2.29 | +1383.60% |
| Q3 2021 | 2021-09-30 | 0.51 | — | — |
| Q4 2020 | 2020-12-31 | 0.17 | — | — |
| Q4 2017 | 2017-12-31 | 10.94 | — | — |
Scinai Immunotherapeutics current ratio trends
Over the last five fiscal years, Scinai Immunotherapeutics's current ratio increased from 0.17 to 1.30, a change of 1.13. The latest reported quarter, Q2 2026, shows 1.56.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗